Arcturus Therapeutics Ltd (ARCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 2,061 | 7,197 | 17,151 | 28,301 | 29,382 |
| Gross Profit | 2,061 | 7,197 | 17,151 | 28,301 | 29,382 |
| Operating Expenses | 30,992 | 38,503 | 33,663 | 39,917 | 46,208 |
| Operating Income | -28,931 | -31,306 | -16,512 | -11,616 | -16,826 |
| Interest Expense | -1,932 | -1,523 | -3,234 | -2,567 | -2,771 |
| Other Income | 35 | 700 | -170 | -127 | -21 |
| Pre-tax Income | -26,964 | -29,083 | -13,448 | -9,176 | -14,076 |
| Income Tax | N/A | N/A | N/A | 4 | N/A |
| Net Income Continuous | -26,964 | -29,079 | -13,448 | -9,180 | -14,076 |
| Net Income | $-26,964 | $-29,079 | $-13,448 | $-9,180 | $-14,076 |
| EPS Basic Total Ops | -0.95 | -1.05 | -0.49 | -0.34 | -0.52 |
| EPS Basic Continuous Ops | -0.95 | -1.05 | -0.49 | -0.34 | -0.52 |
| EPS Diluted Total Ops | -0.95 | -1.05 | -0.49 | -0.34 | -0.52 |
| EPS Diluted Continuous Ops | -0.95 | -1.05 | -0.49 | -0.34 | -0.52 |
| EPS Diluted Before Non-Recurring Items | -0.95 | -1.03 | -0.49 | -0.34 | -0.52 |
| EBITDA(a) | $-28,273 | $-30,624 | $-15,749 | $-10,837 | $-16,025 |